NanoString Technologies Releases Financial Results for Second Quarter of 2014

Go back to NanoString Technologies Releases Financial Results for Second Quarter of 2014

Nanostring Tech (NSTG) Tops Q2 EPS by 7c; Receives Approval in Australia for Prosigna Assay

August 5, 2014 4:52 PM EDT

Nanostring Tech (NASDAQ: NSTG) reported Q2 EPS of ($0.58), $0.07 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $10.9 million versus the consensus estimate of $10.2 million.

The company also announced that it has received market approval from the Australian Therapeutic Goods... More